Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.06−0.53 (-4.21%)
Close on Nov 17, 2026Market cap $846.23MP/E 301.5Yield –
Pharming pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Pharming's pe ratio was 335.0× on Nov 11, 2026, against 60.8× a year earlier. Over the last 4 years it ranged from 14.6× to 416.0×, with a median of 53.1×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 335.0× | +274.7 |
| 2024 | Feb 29, 2024 | 60.3× | +0.1 |
| 2023 | Dec 29, 2023 | 60.2× | +12.2 |
| 2022 | Dec 30, 2022 | 48.0× | +31.7 |
| 2021 | Dec 31, 2021 | 16.3× | −9.1 |
| 2020 | Dec 31, 2020 | 25.3× | – |
See a number that looks wrong?